NCT06056037Completed
Making ART Work Among Brazilian Youth
Making Universal, Free-of-charge Antiretroviral Therapy Work for Sexual and Gender Minority Youth in Brazil
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 19 Sept 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 22 May 2026
- Lead sponsor
- Brown University
- Diseases
- HIV
- NCT number
- NCT06056037
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Oct 2023 to the primary completion date, 22 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication
Other
- unable to read and/or write to an extent that would limit their ability to comprehend the informed consent
- lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year
Who the study is looking for
- between 18 and 24 years of age
- assigned male sex at birth
- identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum
- self-report living with HIV, and verified by medical chart review,
- self-report currently taking or prescribed ART for \> 3 months
- self-report missing 2 or more doses of ART medications in any given week in the past month OR not virally suppressed (i.e., \>40 copies/mL in past 3 months; via national outpatient data \[SISCEL\] or plasma viral load testing)
- owns a cell phone or willing to use one as part of the study
Age in the registry: 18 years to 24 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Evandro Chagas National Institute of Infectious Diseases (INI) Oswaldo Cruz Foundation (FIOCRUZ) Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.